Influence  ||| S:0 E:10 ||| NN
of  ||| S:10 E:13 ||| IN
deleted  ||| S:13 E:21 ||| VBN
in  ||| S:21 E:24 ||| IN
colorectal  ||| S:24 E:35 ||| JJ
carcinoma  ||| S:35 E:45 ||| JJ
gene  ||| S:45 E:50 ||| NN
on  ||| S:50 E:53 ||| IN
proliferation  ||| S:53 E:67 ||| NN
of  ||| S:67 E:70 ||| IN
ovarian  ||| S:70 E:78 ||| JJ
cancer  ||| S:78 E:85 ||| NN
cell  ||| S:85 E:90 ||| NN
line  ||| S:90 E:95 ||| NN
SKOV-3  ||| S:95 E:102 ||| NN
in  ||| S:102 E:105 ||| IN
vivo  ||| S:105 E:110 ||| NN
and  ||| S:110 E:114 ||| CC
in  ||| S:114 E:117 ||| IN
vitro  ||| S:117 E:123 ||| VBG
To  ||| S:123 E:126 ||| TO
elucidate  ||| S:126 E:136 ||| VB
the  ||| S:136 E:140 ||| DT
effects  ||| S:140 E:148 ||| NNS
of  ||| S:148 E:151 ||| IN
the  ||| S:151 E:155 ||| DT
deleted  ||| S:155 E:163 ||| NN
in  ||| S:163 E:166 ||| IN
colorectal  ||| S:166 E:177 ||| JJ
carcinoma  ||| S:177 E:187 ||| NNS
( ||| S:187 E:188 ||| -LRB-
DCC ||| S:188 E:191 ||| NNP
)  ||| S:191 E:193 ||| -RRB-
gene  ||| S:193 E:198 ||| NN
on  ||| S:198 E:201 ||| IN
proliferation  ||| S:201 E:215 ||| NN
of  ||| S:215 E:218 ||| IN
ovarian  ||| S:218 E:226 ||| JJ
cancer  ||| S:226 E:233 ||| NN
cell  ||| S:233 E:238 ||| NN
line  ||| S:238 E:243 ||| NN
SKOV-3 ||| S:243 E:249 ||| NN
.  ||| S:249 E:251 ||| .
An  ||| S:251 E:254 ||| DT
exogenous  ||| S:254 E:264 ||| FW
recombinant  ||| S:264 E:276 ||| FW
eukaryotic  ||| S:276 E:287 ||| FW
expression  ||| S:287 E:298 ||| FW
vector  ||| S:298 E:305 ||| FW
pcDNA3.1 ||| S:305 E:313 ||| FW
( ||| S:313 E:314 ||| -LRB-
+ ||| S:314 E:315 ||| NNP
) ||| S:315 E:316 ||| -RRB-
-DCC ||| S:316 E:320 ||| NNP
,  ||| S:320 E:322 ||| ,
containing  ||| S:322 E:333 ||| VBG
human  ||| S:333 E:339 ||| JJ
DCC  ||| S:339 E:343 ||| FW
cDNA  ||| S:343 E:348 ||| FW
coding  ||| S:348 E:355 ||| FW
sequences ||| S:355 E:364 ||| FW
,  ||| S:364 E:366 ||| ,
was  ||| S:366 E:370 ||| VBD
constructed  ||| S:370 E:382 ||| VBN
and  ||| S:382 E:386 ||| CC
transfected  ||| S:386 E:398 ||| NN
into  ||| S:398 E:403 ||| IN
SKOV-3  ||| S:403 E:410 ||| CD
cells  ||| S:410 E:416 ||| NNS
( ||| S:416 E:417 ||| -LRB-
SKOV-3 ||| S:417 E:423 ||| NNP
/ ||| S:423 E:424 ||| NNP
DCC ||| S:424 E:427 ||| NNP
) ||| S:427 E:428 ||| -RRB-
.  ||| S:428 E:430 ||| .
The  ||| S:430 E:434 ||| DT
pcDNA3.1  ||| S:434 E:443 ||| NNP
( ||| S:443 E:444 ||| -LRB-
+ ||| S:444 E:445 ||| NNP
)  ||| S:445 E:447 ||| -RRB-
transfected  ||| S:447 E:459 ||| JJ
cells  ||| S:459 E:465 ||| NNS
( ||| S:465 E:466 ||| -LRB-
SKOV-3 ||| S:466 E:472 ||| NNP
/ ||| S:472 E:473 ||| NNP
Neo ||| S:473 E:476 ||| NNP
)  ||| S:476 E:478 ||| -RRB-
and  ||| S:478 E:482 ||| CC
SKOV-3  ||| S:482 E:489 ||| CD
cells  ||| S:489 E:495 ||| NNS
were  ||| S:495 E:500 ||| VBD
used  ||| S:500 E:505 ||| VBN
as  ||| S:505 E:508 ||| IN
the  ||| S:508 E:512 ||| DT
positive  ||| S:512 E:521 ||| JJ
and  ||| S:521 E:525 ||| CC
negative  ||| S:525 E:534 ||| JJ
controls ||| S:534 E:542 ||| NNS
,  ||| S:542 E:544 ||| ,
respectively ||| S:544 E:556 ||| RB
.  ||| S:556 E:558 ||| .
Expressions  ||| S:558 E:570 ||| NNS
of  ||| S:570 E:573 ||| IN
DCC  ||| S:573 E:577 ||| NNP
mRNA  ||| S:577 E:582 ||| NNP
and  ||| S:582 E:586 ||| CC
protein  ||| S:586 E:594 ||| NN
were  ||| S:594 E:599 ||| VBD
analyzed  ||| S:599 E:608 ||| VBN
by  ||| S:608 E:611 ||| IN
RT-PCR  ||| S:611 E:618 ||| JJ
and  ||| S:618 E:622 ||| CC
immunocytochemical  ||| S:622 E:641 ||| JJ
analysis ||| S:641 E:649 ||| NN
,  ||| S:649 E:651 ||| ,
respectively ||| S:651 E:663 ||| RB
.  ||| S:663 E:665 ||| .
Cell  ||| S:665 E:670 ||| NN
growth  ||| S:670 E:677 ||| NN
was  ||| S:677 E:681 ||| VBD
detected  ||| S:681 E:690 ||| VBN
by  ||| S:690 E:693 ||| IN
soft  ||| S:693 E:698 ||| JJ
agar  ||| S:698 E:703 ||| JJ
colony  ||| S:703 E:710 ||| NN
formation  ||| S:710 E:720 ||| NN
assay  ||| S:720 E:726 ||| NNS
and  ||| S:726 E:730 ||| CC
MTT  ||| S:730 E:734 ||| NNP
assay ||| S:734 E:739 ||| NN
.  ||| S:739 E:741 ||| .
Flow  ||| S:741 E:746 ||| NN
cytometry  ||| S:746 E:756 ||| NNS
and  ||| S:756 E:760 ||| CC
transmission  ||| S:760 E:773 ||| JJ
electron  ||| S:773 E:782 ||| JJ
microscopy  ||| S:782 E:793 ||| NN
were  ||| S:793 E:798 ||| VBD
used  ||| S:798 E:803 ||| VBN
to  ||| S:803 E:806 ||| TO
assess  ||| S:806 E:813 ||| VB
the  ||| S:813 E:817 ||| DT
effects  ||| S:817 E:825 ||| NNS
of  ||| S:825 E:828 ||| IN
DCC  ||| S:828 E:832 ||| NNP
on  ||| S:832 E:835 ||| IN
cell  ||| S:835 E:840 ||| NN
cycle  ||| S:840 E:846 ||| NN
distribution  ||| S:846 E:859 ||| NN
and  ||| S:859 E:863 ||| CC
ultrastructure ||| S:863 E:877 ||| NN
,  ||| S:877 E:879 ||| ,
respectively ||| S:879 E:891 ||| RB
.  ||| S:891 E:893 ||| .
BALB ||| S:893 E:897 ||| NNP
/ ||| S:897 E:898 ||| NNP
c  ||| S:898 E:900 ||| NN
mice  ||| S:900 E:905 ||| NNS
were  ||| S:905 E:910 ||| VBD
used  ||| S:910 E:915 ||| VBN
to  ||| S:915 E:918 ||| TO
evaluate  ||| S:918 E:927 ||| VB
the  ||| S:927 E:931 ||| DT
effects  ||| S:931 E:939 ||| NNS
of  ||| S:939 E:942 ||| IN
DCC  ||| S:942 E:946 ||| NNP
on  ||| S:946 E:949 ||| IN
tumorigenicity  ||| S:949 E:964 ||| NN
in  ||| S:964 E:967 ||| IN
vivo ||| S:967 E:971 ||| NN
.  ||| S:971 E:973 ||| .
RT-PCR  ||| S:973 E:980 ||| NNP
and  ||| S:980 E:984 ||| CC
immunocytochemical  ||| S:984 E:1003 ||| JJ
analysis  ||| S:1003 E:1012 ||| NN
revealed  ||| S:1012 E:1021 ||| VBD
the  ||| S:1021 E:1025 ||| DT
exogenous  ||| S:1025 E:1035 ||| JJ
DCC  ||| S:1035 E:1039 ||| NNP
gene  ||| S:1039 E:1044 ||| NN
was  ||| S:1044 E:1048 ||| VBD
successfully  ||| S:1048 E:1061 ||| RB
transfected  ||| S:1061 E:1073 ||| VBN
into  ||| S:1073 E:1078 ||| IN
SKOV-3  ||| S:1078 E:1085 ||| CD
cell  ||| S:1085 E:1090 ||| NN
lines  ||| S:1090 E:1096 ||| NNS
and  ||| S:1096 E:1100 ||| CC
obtained  ||| S:1100 E:1109 ||| VBD
permanent  ||| S:1109 E:1119 ||| JJ
expression ||| S:1119 E:1129 ||| NN
.  ||| S:1129 E:1131 ||| .
The  ||| S:1131 E:1135 ||| DT
half  ||| S:1135 E:1140 ||| NN
maximal  ||| S:1140 E:1148 ||| FW
inhibitory  ||| S:1148 E:1159 ||| FW
concentration  ||| S:1159 E:1173 ||| FW
( ||| S:1173 E:1174 ||| -LRB-
IC50 ||| S:1174 E:1178 ||| NNP
)  ||| S:1178 E:1180 ||| -RRB-
of  ||| S:1180 E:1183 ||| IN
SKOV-3 ||| S:1183 E:1189 ||| NNP
/ ||| S:1189 E:1190 ||| NNP
DCC  ||| S:1190 E:1194 ||| NNP
cells  ||| S:1194 E:1200 ||| NNS
was  ||| S:1200 E:1204 ||| VBD
significantly  ||| S:1204 E:1218 ||| RB
lower  ||| S:1218 E:1224 ||| JJR
than  ||| S:1224 E:1229 ||| IN
that  ||| S:1229 E:1234 ||| DT
of  ||| S:1234 E:1237 ||| IN
SKOV-3  ||| S:1237 E:1244 ||| NNP
or  ||| S:1244 E:1247 ||| CC
SKOV-3 ||| S:1247 E:1253 ||| NNP
/ ||| S:1253 E:1254 ||| NNP
Neo  ||| S:1254 E:1258 ||| NNP
cells  ||| S:1258 E:1264 ||| NNS
( ||| S:1264 E:1265 ||| -LRB-
all  ||| S:1265 E:1269 ||| DT
P  ||| S:1269 E:1270 ||| NN
< ||| S:1270 E:1271 ||| SYM
0.05 ||| S:1271 E:1275 ||| CD
) ||| S:1275 E:1276 ||| -RRB-
.  ||| S:1276 E:1278 ||| .
DCC  ||| S:1278 E:1282 ||| NNP
expression  ||| S:1282 E:1293 ||| NN
caused  ||| S:1293 E:1300 ||| VBD
SKOV-3  ||| S:1300 E:1307 ||| CD
cells  ||| S:1307 E:1313 ||| NNS
to  ||| S:1313 E:1316 ||| TO
be  ||| S:1316 E:1319 ||| VB
arrested  ||| S:1319 E:1328 ||| VBN
in  ||| S:1328 E:1331 ||| IN
G1  ||| S:1331 E:1334 ||| CD
phase  ||| S:1334 E:1340 ||| NN
( ||| S:1340 E:1341 ||| -LRB-
78.0 ||| S:1341 E:1345 ||| NNP
% ||| S:1345 E:1346 ||| NN
) ||| S:1346 E:1347 ||| -RRB-
,  ||| S:1347 E:1349 ||| ,
and  ||| S:1349 E:1353 ||| CC
electron  ||| S:1353 E:1362 ||| JJ
microscopic  ||| S:1362 E:1374 ||| JJ
analysis  ||| S:1374 E:1383 ||| NN
showed  ||| S:1383 E:1390 ||| VBD
SKOV-3 ||| S:1390 E:1396 ||| NNP
/ ||| S:1396 E:1397 ||| NNP
DCC  ||| S:1397 E:1401 ||| NNP
cells  ||| S:1401 E:1407 ||| NNS
displayed  ||| S:1407 E:1417 ||| VBD
typical  ||| S:1417 E:1425 ||| JJ
morphological  ||| S:1425 E:1439 ||| JJ
changes  ||| S:1439 E:1447 ||| NNS
of  ||| S:1447 E:1450 ||| IN
apoptosis ||| S:1450 E:1459 ||| NN
.  ||| S:1459 E:1461 ||| .
Two  ||| S:1461 E:1465 ||| CD
mice  ||| S:1465 E:1470 ||| NNS
xenografted  ||| S:1470 E:1482 ||| VBN
with  ||| S:1482 E:1487 ||| IN
SKOV-3 ||| S:1487 E:1493 ||| NNP
/ ||| S:1493 E:1494 ||| NNP
DCC  ||| S:1494 E:1498 ||| NNP
cells  ||| S:1498 E:1504 ||| NNS
showed  ||| S:1504 E:1511 ||| VBD
no  ||| S:1511 E:1514 ||| DT
tumor  ||| S:1514 E:1520 ||| NN
tumorigenecity ||| S:1520 E:1534 ||| NN
.  ||| S:1534 E:1536 ||| .
The  ||| S:1536 E:1540 ||| DT
tumor  ||| S:1540 E:1546 ||| NN
volume  ||| S:1546 E:1553 ||| NN
of  ||| S:1553 E:1556 ||| IN
BALB ||| S:1556 E:1560 ||| NNP
/ ||| S:1560 E:1561 ||| NNP
c  ||| S:1561 E:1563 ||| SYM
mice  ||| S:1563 E:1568 ||| FW
bearing  ||| S:1568 E:1576 ||| FW
SKOV-3 ||| S:1576 E:1582 ||| FW
/ ||| S:1582 E:1583 ||| FW
DCC  ||| S:1583 E:1587 ||| FW
cells  ||| S:1587 E:1593 ||| FW
( ||| S:1593 E:1594 ||| -LRB-
3.403  ||| S:1594 E:1600 ||| FW
mm ||| S:1600 E:1602 ||| FW
( ||| S:1602 E:1603 ||| -LRB-
3 ||| S:1603 E:1604 ||| LS
) ||| S:1604 E:1605 ||| -RRB-
)  ||| S:1605 E:1607 ||| -RRB-
was  ||| S:1607 E:1611 ||| VBD
smaller  ||| S:1611 E:1619 ||| JJR
than  ||| S:1619 E:1624 ||| IN
that  ||| S:1624 E:1629 ||| DT
of  ||| S:1629 E:1632 ||| IN
SKOV-3  ||| S:1632 E:1639 ||| CD
cells  ||| S:1639 E:1645 ||| NNS
( ||| S:1645 E:1646 ||| -LRB-
9.206  ||| S:1646 E:1652 ||| FW
mm ||| S:1652 E:1654 ||| FW
( ||| S:1654 E:1655 ||| -LRB-
3 ||| S:1655 E:1656 ||| LS
) ||| S:1656 E:1657 ||| -RRB-
) ||| S:1657 E:1658 ||| -RRB-
.  ||| S:1658 E:1660 ||| .
DCC  ||| S:1660 E:1664 ||| NNP
gene  ||| S:1664 E:1669 ||| NN
may  ||| S:1669 E:1673 ||| MD
play  ||| S:1673 E:1678 ||| VB
an  ||| S:1678 E:1681 ||| DT
important  ||| S:1681 E:1691 ||| JJ
role  ||| S:1691 E:1696 ||| NN
in  ||| S:1696 E:1699 ||| IN
suppressing  ||| S:1699 E:1711 ||| VBG
the  ||| S:1711 E:1715 ||| DT
growth  ||| S:1715 E:1722 ||| NN
of  ||| S:1722 E:1725 ||| IN
SKOV-3  ||| S:1725 E:1732 ||| CD
cell  ||| S:1732 E:1737 ||| NN
line  ||| S:1737 E:1742 ||| NN
and  ||| S:1742 E:1746 ||| CC
inducing  ||| S:1746 E:1755 ||| JJ
apoptosis ||| S:1755 E:1764 ||| NN
.  ||| S:1764 E:1766 ||| .
